Skip to content

The perspective clinical study on acute lymphoblastic leukemia with VDPCP regimen

The perspective clinical study on acute lymphoblastic leukemia with VDPCP regimen

Status
Recruiting
Phases
Phase 2
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONRC-14004968
Enrollment
Unknown
Registered
2014-07-08
Start date
2014-07-18
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute lymphoblastic leukemia

Interventions

Sponsors

Rui Jin hospital affiliated to Shanghai Jiaotong University School of Medicine, Shanghai Institute of Hematology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Newly diagnosed acute leukemia;heart function: no severe heart diseases;liver and kidney function: ALT and AST less than 2 times the upper limit of normal range; the serum bilirubin less than 1.5 times the upper limit of normal range; Normal serum amylase, no previous history of pancreatitis; Signed informed consent.

Exclusion criteria

Exclusion criteria: History of other cancers, except basal cell carcinoma; with contraindications of corticosteroids; diabetes which cannot be successfully controlled; HIV and syphilis-infected patients; pregnancy or lactating women; patients previously received an organ transplantation; severe neurological or psychiatric history.

Design outcomes

Primary

MeasureTime frame
overall survival;complete remission rate;minimal residual diseas;

Secondary

MeasureTime frame
progression-free survival;time to progression;safety;

Countries

China

Contacts

Public ContactJianqing Mi, Jin Wang
jianqingmi@shsmu.edu.cn+86 021-64370045-601803

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026